Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2
ACS Infectious Diseases · 14.04.2023 · 9 (4) · 1033-1045
DOI: 10.1021/acsinfecdis.3c00034 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 13.03.2023. Verfasst von Hyeon-Min Cha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Orthomyxoviridae. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, Korea Research Institute of Chemical Technology, National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
- Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
- ST Pharm Co., Ltd., Seoul 06194, Republic of Korea.
- College of Pharmacy, Dongguk University, Goyang-si, Gyeonggi-do 10326, Republic of Korea.
- Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
ORCID-Profile: Haemi Lee, Seong Soon Kim, Meehyein Kim
Förderung
- Ministry of Health and Welfare
- Korea Research Institute of Chemical Technology
- National Research Foundation of Korea
- ST Pharm Co.
Zitieren
APA
Cha, H. M., Kim, U. I., Ahn, S. B., Lee, M. K., Lee, H., Bang, H., Jang, Y., Kim, S. S., Bae, M. A., Kim, K., & Kim, M. (2023). Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2. ACS Infectious Diseases, 9(4), 1033-1045. https://doi.org/10.1021/acsinfecdis.3c00034
Vancouver
Cha HM, Kim UI, Ahn SB, Lee MK, Lee H, Bang H, et al. Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2. ACS Infectious Diseases. 2023;9(4):1033-1045. doi:10.1021/acsinfecdis.3c00034
BibTeX
@article{Cha2023,
author = {Cha, Hyeon-Min and Kim, Uk-Il and Ahn, Soo Bin and Lee, Myoung Kyu and Lee, Haemi and Bang, Hyungtae and Jang, Yejin and Kim, Seong Soon and Bae, Myung Ae and Kim, Kyungjin and Kim, Meehyein},
title = {Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2},
journal = {ACS Infectious Diseases},
year = {2023},
volume = {9},
number = {4},
pages = {1033--1045},
doi = {10.1021/acsinfecdis.3c00034}
}
EUVIMED